Relpax (eletriptan) carries an average cash price of roughly $573 for just six tablets at the brand-name level, making it one of the most expensive migraine medications on the pharmacy shelf. The price comes down to a combination of limited generic competition, the way US drug pricing works compared to other countries, and insurance practices that push many patients toward paying more out of pocket than they’d expect.
What Brand-Name Relpax Actually Costs
At full retail, a single 40mg Relpax tablet runs close to $95. That puts a six-tablet supply, which many migraine patients can go through in a month, near $573. Even the generic version, eletriptan hydrobromide, isn’t cheap. Depending on your pharmacy, six generic tablets range from about $173 at CVS to nearly $370 at Kroger. Walmart and Walgreens fall somewhere in between, around $195 to $340. These are cash prices without insurance or discount cards applied.
For comparison, European patients pay roughly €10 to €15 per dose for the same medication. That’s a fraction of the US price, and the gap exists because many European governments negotiate drug prices directly with manufacturers, setting hard ceilings on what pharmacies can charge. The US has no equivalent system for most prescription drugs, leaving manufacturers free to set prices based on what the market will bear.
Why the Generic Isn’t Much Cheaper
Generic drugs typically slash the price of a brand-name medication by 80% or more once multiple manufacturers start competing. Eletriptan hasn’t followed that pattern. The generic market for this particular triptan has fewer competing manufacturers than blockbuster generics like sumatriptan, which keeps prices elevated. Viatris, which has ties to the original Pfizer marketing authorization for Relpax, produces both the brand and a version of the generic product, a dynamic that doesn’t always drive prices down as aggressively as having several independent generic makers.
Sumatriptan, the oldest triptan on the market, has been available in generic form for much longer and from many more manufacturers. You can find generic sumatriptan for under $30 for a comparable supply. That price difference is largely about competition: more manufacturers producing the same molecule means pharmacies can shop around, and prices drop.
How Relpax Differs From Cheaper Triptans
All triptans work through the same basic mechanism, activating serotonin receptors in the brain to constrict blood vessels and interrupt migraine signaling. Eletriptan stands out on a couple of pharmacological measures. Its half-life is longer than sumatriptan’s two hours, meaning it stays active in your system longer and may reduce the chance of a migraine coming back after the first dose wears off. Some patients find it more effective or better tolerated than sumatriptan or rizatriptan, which is part of why they’re willing to pay the premium or why their doctor prescribed it specifically.
That clinical edge, even if modest, gives the manufacturer pricing leverage. Patients who’ve tried cheaper triptans without success are a somewhat captive market. Their doctors will write the prescription for eletriptan because it works for that patient, and switching to save money isn’t always practical when you’re dealing with debilitating migraine episodes.
Insurance Coverage and Access Barriers
Insurance plans commonly place eletriptan on a mid-tier formulary position, which means higher copays than preferred generics like sumatriptan. The VA system, for example, lists eletriptan as a Tier 2 formulary item and caps oral triptan prescriptions at 18 doses per month. Many commercial insurers impose similar quantity limits and may require prior authorization or step therapy, meaning your doctor has to document that you tried a cheaper triptan first before the plan will cover eletriptan.
These hurdles don’t just slow down access. They sometimes push patients toward paying cash when the prior authorization process takes too long or gets denied, and cash prices for eletriptan are where the real sticker shock hits.
US Drug Pricing Plays a Major Role
The single biggest reason Relpax costs what it does in the US is structural. American drug pricing operates through a layered system of manufacturers, wholesalers, pharmacy benefit managers, and insurers, each taking a margin. The wholesale acquisition cost for Relpax sits around $40 to $50 per tablet before retail markups, discounts, and rebates get factored in. In Europe, where governments negotiate directly and set reimbursement ceilings, the same tablet costs a third to a quarter of the US price.
This isn’t unique to Relpax. Nearly every brand-name medication costs significantly more in the US than in countries with centralized price negotiations. But for a drug like Relpax, where the generic alternative hasn’t driven prices down as far as patients expect, the gap feels especially painful.
Ways to Reduce Your Cost
The manufacturer offers a savings card through relpax.com that covers up to $250 per fill, with a $3,000 annual cap. There are significant restrictions, though. You need private commercial insurance to qualify. If you’re on Medicare, Medicaid, TRICARE, or any state or federal insurance program, you’re not eligible. Cash-paying patients without insurance also can’t use the card. And if your insurer runs a copay accumulator or maximizer program, which prevents manufacturer discounts from counting toward your deductible, the card’s value is effectively neutralized.
For patients who don’t qualify for the savings card, pharmacy discount programs like SingleCare or GoodRx can bring generic eletriptan down closer to $170 to $200 for six tablets. That’s still not cheap, but it’s a meaningful reduction from the $340 to $370 some pharmacies charge at full retail. Asking your pharmacist to run prices at multiple nearby locations is worth the effort, since the spread between pharmacies can be over $100 for the same generic product.
If cost is a dealbreaker and you haven’t tried other triptans, talking with your doctor about sumatriptan or rizatriptan could save you hundreds of dollars per month. These aren’t identical to eletriptan, but many migraine patients respond well to more than one triptan, and the price difference is substantial enough to make it worth exploring.

